Barbara Bohle Selected Research

Single-Domain Antibodies

1/2022

Isolation of nanobodies with potential to reduce patients' IgE binding to Bet v 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Barbara Bohle Research Topics

Disease

59	Hypersensitivity (Allergy) 03/2024 - 01/2002
22	Seasonal Allergic Rhinitis (Hay Fever) 01/2023 - 11/2002
17	Food Hypersensitivity (Food Allergy) 08/2022 - 03/2004
6	Inflammation (Inflammations) 01/2022 - 11/2004
3	Atopic Dermatitis (Atopic Eczema) 06/2008 - 05/2004
2	Pneumonia (Pneumonitis) 01/2023 - 05/2018
2	Asthma (Bronchial Asthma) 01/2022 - 05/2018
2	Infections 01/2022 - 01/2021
2	Leukemia 10/2017 - 03/2010
2	Immediate Hypersensitivity 02/2011 - 12/2003
2	Anaphylaxis (Anaphylactic Shock) 01/2011 - 04/2003
2	Skin Diseases (Skin Disease) 07/2005 - 05/2004
1	Polyps 10/2023
1	Autoimmune enteropathy 01/2022
1	Celiac Disease (Celiac Sprue) 01/2022
1	Allergic Rhinitis 01/2022
1	Dust Mite Allergy 03/2021
1	Neoplasms (Cancer) 01/2021
1	Rupture 10/2020
1	Blister (Bulla) 01/2019
1	Granuloma 05/2006
1	Eosinophilia 04/2006
1	Hyperhomocysteinemia 12/2003
1	Rheumatoid Arthritis 07/2002

Drug/Important Bio-Agent (IBA)

63	AllergensIBA 03/2024 - 01/2002
29	Immunoglobulin E (IgE)IBA 03/2024 - 04/2003
15	Proteins (Proteins, Gene)FDA Link 10/2023 - 06/2004
13	VaccinesIBA 03/2021 - 06/2004
10	AntibodiesIBA 01/2024 - 07/2005
8	CytokinesIBA 01/2022 - 05/2004
7	Peptides (Polypeptides)IBA 01/2022 - 11/2002
4	Immunoglobulin G (IgG)IBA 01/2024 - 03/2011
4	EpitopesIBA 01/2022 - 02/2005
4	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2019 - 07/2005
3	Interleukin-4 (Interleukin 4)IBA 10/2023 - 07/2009
3	Immunoglobulins (Immunoglobulin)IBA 06/2021 - 11/2004
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2018 - 01/2011
3	AntigensIBA 05/2018 - 11/2002
2	LigandsIBA 01/2022 - 01/2013
2	Interleukin-33IBA 06/2021 - 07/2014
2	Recombinant ProteinsIBA 01/2018 - 03/2005
2	AutoantibodiesIBA 06/2008 - 07/2005
2	AutoantigensIBA 06/2008 - 07/2002
1	InterleukinsIBA 10/2023
1	Chemokine ReceptorsIBA 10/2023
1	Monoclonal AntibodiesIBA 01/2022
1	ProlaminsIBA 01/2022
1	TropomyosinIBA 01/2022
1	Antimicrobial PeptidesIBA 01/2022
1	Glutens (Glutelin)IBA 01/2022
1	Single-Domain AntibodiesIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Complement System Proteins (Complement)IBA 06/2021
1	Blocking AntibodiesIBA 10/2020
1	NADPH Oxidases (NAD(P)H oxidase)IBA 10/2020
1	aluminum sulfate (alum)IBA 10/2020
1	Interleukin-3 (Interleukin 3)IBA 01/2019
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2019
1	Codon (Codons)IBA 01/2018
1	FlagellinIBA 01/2018
1	Profilins (Profilin)IBA 10/2017
1	DisulfidesIBA 10/2017
1	SolutionsIBA 08/2017
1	A-factor (Streptomyces)IBA 01/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2013
1	HLA-DR1 Antigen (HLA DR1 Antigen)IBA 08/2012
1	EndotoxinsIBA 02/2011
1	PyrogensIBA 02/2011
1	GlobulinsIBA 01/2011
1	Cysteine (L-Cysteine)FDA Link 03/2010
1	Histocompatibility Antigens Class IIIBA 03/2010
1	Pru p 3 allergenIBA 07/2009
1	integrin beta7IBA 07/2009
1	Interleukin-2 (IL2)IBA 07/2009
1	Interleukin-10 (Interleukin 10)IBA 07/2009
1	ragweed pollenIBA 06/2009
1	nascent-polypeptide-associated complexIBA 06/2008
1	DNA (Deoxyribonucleic Acid)IBA 08/2007
1	LatexIBA 08/2006
1	lipid transfer protein (glycolipid transfer protein)IBA 08/2006
1	OligonucleotidesIBA 02/2005
1	NucleotidesIBA 02/2005
1	Recombinant Fusion ProteinsIBA 06/2004
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 12/2003
1	HomocysteineIBA 12/2003
1	OligodeoxyribonucleotidesIBA 05/2003
1	Analgesics (Analgesic Drugs)IBA 04/2003
1	propyphenazoneIBA 04/2003
1	pyrazoloneIBA 04/2003
1	CPG-oligonucleotideIBA 11/2002
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 07/2002
1	Filaggrin ProteinsIBA 07/2002

Therapy/Procedure

26	Immunotherapy 11/2023 - 01/2002
5	Therapeutics 01/2022 - 03/2004
2	Cell- and Tissue-Based Therapy (Cell Therapy) 03/2024 - 01/2011
1	Oral Administration 01/2017